Development of a self-silencing adenovirus for the efficient manufacture of adeno-associated virus vectors
<p>Adeno-associated virus (AAV) shows great promise for gene therapy, however scalability, yield and quality remain significant issues. The most common ‘helper-free’ method used to produce recombinant AAV (rAAV) for pre-clinical/clinical application is based on plasmid transfection of HEK293 c...
| 1. Verfasser: | |
|---|---|
| Weitere Verfasser: | |
| Format: | Abschlussarbeit |
| Sprache: | English |
| Veröffentlicht: |
2021
|
| Schlagworte: |